{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-24-000069","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.247915+00:00","generated_at":"2026-05-29T00:10:55.532205+00:00","sec_items":["5.05","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Supernus updates Code of Ethics and Business Conduct on Dec 19, 2024","bullets":["Board of Directors approved an updated Code of Ethics and Business Conduct on December 19, 2024.","Updates clarify reporting channels, consequences for violations, conflicts of interest, and compliance guidance.","No waivers or implicit waivers were granted; code will be posted on the Investor Relations website."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-24-000069","json":"https://secwatch.observer/filing/0001356576-24-000069.json","markdown":"https://secwatch.observer/filing/0001356576-24-000069.md","text":"https://secwatch.observer/filing/0001356576-24-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/0001356576-24-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/supn-20241219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:10:55.532205+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}